Withania somnifera/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on adverse event occurrence (oral or enteral supplement)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“The relative risk (RR) of experiencing at least one AE in the ARE group compared with PL was 0.67 (95% CI: 0.42–1.06), suggesting a numerically lower, though not statistically significant, AE incidence in the Ashwagandha group.”
Quoted verbatim from Safety of 8-Week Administration With Ashwagandha (Withania somnifera) Root Extract in Adults With Stress and Anxiety: Findings From a Prospective, Randomized, Multi-Center, Double-Blinded, Placebo-Controlled Study.. - Study
- RCT
- Participants
- 1,002
- Duration
- 8 weeks
- Dose
- 300 mg capsule orally twice daily (600 mg/day), after breakfast and after dinner, for 8 weeks
- Population
- adults aged 18 to 65 with reported stress and anxiety (HAM-A total 14-30, Cohen PSS 13 or above), enrolled at 15 sites across India, Australia, the United States, Portugal and Africa
Effect 0.67 risk ratio, 95% CI 0.42 to 1.06
Safety of 8-Week Administration With Ashwagandha (Withania somnifera) Root Extract in Adults With Stress and Anxiety: Findings From a Prospective, Randomized, Multi-Center, Double-Blinded, Placebo-Controlled Study.2026PMID:41943502Industry fundedPermalink
Keep reading
- Everything the graph holds on Withania somnifera
- Every compound studied against Adverse event occurrence (oral or enteral supplement)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M12YPB79AEZ7T73FMG5A040Z